Stage II Uterine Corpus Cancer Clinical Trial
Official title:
The Relationship of Racial Genetic Admixture With Endometrial Cancer Outcomes
This research study is studying racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. DNA analysis of tumor tissue may also help doctors predict how well patients will respond to treatment.
PRIMARY OBJECTIVES:
I. To identify racial categorization as the proportion of genetic background of
African-American or European-American women with endometrioid endometrial cancer (EEC).
II. To evaluate the association of racial genetic admixture with clinicopathologic variables
and outcomes.
SECONDARY OBJECTIVES:
I. To compare the concordance between racial genetic admixture and self-designated race
categorization.
OUTLINE: This is a multicenter study. Patients are stratified by race (African-American vs
European-American) and disease stage (I vs II vs III vs IV).
DNA from archived frozen normal tissue samples is genotyped for the ancestry informative
markers. Clinicopathological and demographic characteristics associated with each sample are
also collected.
;
Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01208467 -
Prognostic Biomarkers in Patients With Endometrial Cancer
|
N/A | |
| Completed |
NCT02575872 -
Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors
|
N/A | |
| Completed |
NCT01522820 -
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT00956670 -
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
|
N/A | |
| Completed |
NCT00897442 -
Collecting Tumor Samples From Patients With Gynecological Tumors
|
N/A | |
| Completed |
NCT01098630 -
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
|
||
| Recruiting |
NCT03422198 -
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT01344837 -
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
|
N/A | |
| Not yet recruiting |
NCT01199250 -
Biomarkers in Samples From Patients With Endometrial Cancer
|
N/A | |
| Terminated |
NCT01041027 -
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
|
Phase 2 | |
| Terminated |
NCT00577317 -
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
|
Phase 3 | |
| Completed |
NCT02342730 -
Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia
|
N/A | |
| Completed |
NCT03198286 -
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
|
N/A | |
| Completed |
NCT00002706 -
Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
|
Phase 3 |